SPONSOR
Abbisko Therapeutics Co, Ltd
Total Trials
3
Recruiting
3
Phases
Phase 1
NCT07007546 Phase 1
Recruiting
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants
Healthy
NCT07288957 Phase 1
Recruiting
A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors
Solid Tumors (Phase 1)
NCT05244551 Phase 1
Recruiting
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors
Solid Tumor